degeneration

Documents about degeneration

• NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration#845848ClinicalTrials.gov
• X-82 to Treat Age-related Macular Degeneration#870406ClinicalTrials.gov
• The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration#1184175ClinicalTrials.gov
• Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration#1030417ClinicalTrials.gov
• Complications of Age-Related Macular Degeneration Prevention Trial#1152559ClinicalTrials.gov
• Randomized Trial of Beta-Carotene and Macular Degeneration#1162565ClinicalTrials.gov
• Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse#864871ClinicalTrials.gov
• Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration#1033391ClinicalTrials.gov
• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)#892667ClinicalTrials.gov
• Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration#829958ClinicalTrials.gov
• Study of Dark Adaptation in Age-Related Macular Degeneration#839407ClinicalTrials.gov
• PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration#1087603ClinicalTrials.gov
• Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)#1150177ClinicalTrials.gov
• Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration#1151531ClinicalTrials.gov
• BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration#879900ClinicalTrials.gov
• LEAP Strategy for Neovascular Age-Related Macular Degeneration#910498ClinicalTrials.gov
• Copaxone in Age Related Macular Degeneration#967990ClinicalTrials.gov
• Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration#979775ClinicalTrials.gov
• PRIMA US-Feasibility Study in Atrophic Dry AMD#861247ClinicalTrials.gov
• Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular Degeneration#800604ClinicalTrials.gov
• Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)#846963ClinicalTrials.gov
• Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)#1113642ClinicalTrials.gov
• Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)#1111486ClinicalTrials.gov
• Fluocinolone Implant to Treat Macular Degeneration#807272ClinicalTrials.gov
• A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration#896032ClinicalTrials.gov
• Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy#915751ClinicalTrials.gov
• Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)#917044ClinicalTrials.gov
• Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration#800185ClinicalTrials.gov
• Cell Collection to Study Eye Diseases#917286ClinicalTrials.gov
• Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)#806978ClinicalTrials.gov
• EAGLE: Evaluating Genotypes Using Intravitreal Aflibercept Injection#908768ClinicalTrials.gov
• A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration#1139548ClinicalTrials.gov
• Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)#1164213ClinicalTrials.gov
• Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD#913086ClinicalTrials.gov
• Alpha MSH in Ocular Disease#903916ClinicalTrials.gov
• Clinical and Genetic Analyzes of Age-related Macular Degeneration#918850ClinicalTrials.gov
• Treatment -Resistant Neovascular Age-Related Macular Degeneration#1111952ClinicalTrials.gov
• A Study to Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration#803155ClinicalTrials.gov
• Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.#807025ClinicalTrials.gov
• Neovascular Age-related Macular Degeneration#899492ClinicalTrials.gov
• Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration#906886ClinicalTrials.gov
• First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration#832449ClinicalTrials.gov
• Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-04)#876631ClinicalTrials.gov
• A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)#851103ClinicalTrials.gov
• Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration#1007912ClinicalTrials.gov
• Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration#1008676ClinicalTrials.gov
• Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan#1031309ClinicalTrials.gov
• Therapy of Age-related Macular Degeneration#1111557ClinicalTrials.gov
• HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration#801558ClinicalTrials.gov
• A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)#829256ClinicalTrials.gov